Long‐term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac‐inactivated booster: A 7‐month follow‐up study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28279
Abstract: The long‐term protective efficacy of neutralizing antibodies (Nabs) against Omicron subvariants after inactivated booster vaccines remains elusive. During the follow‐up study, 54 healthy volunteers aged 20–31 years received inactivated CoronaVac booster vaccinations and were monitored… read more here.
Keywords: long term; omicron subvariants; booster; neutralizing antibodies ... See more keywords
Emerging Omicron subvariants evade neutralizing immunity elicited by vaccine or BA.1/BA.2 infection
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28539
Abstract: The newly emerging severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron BA.2.75 and BA.2.76 subvariants contained 35 and 29 additional mutations in its spike (S) protein compared with the reference SARS‐CoV‐2 genome, respectively. Here, we… read more here.
Keywords: omicron subvariants; emerging omicron; infection; neutralizing immunity ... See more keywords
Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28788
Abstract: Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by… read more here.
Keywords: sensitivity; omicron subvariants; antigen tests; rapid antigen ... See more keywords
A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Medical Virology"
DOI: 10.1002/jmv.29528
Abstract: The emerging Omicron subvariants have a remarkable ability to spread and escape nearly all current monoclonal antibody (mAb) treatments. Although the virulence of SARS‐CoV‐2 has now diminished, it remains a significant threat to public health… read more here.
Keywords: panel multivalent; panel; xbb; omicron ... See more keywords
Deep Sequencing Reveals Dual Evolution of SARS‐CoV‐2: Insights Into Defective Genomes From Wuhan‐Hu‐1 Variants to Omicron Subvariants
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Medical Virology"
DOI: 10.1002/jmv.70476
Abstract: SARS‐CoV‐2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike… read more here.
Keywords: sars cov; dual evolution; deep sequencing; reveals dual ... See more keywords
Reproduction numbers of SARS-CoV-2 Omicron subvariants
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Travel Medicine"
DOI: 10.1093/jtm/taac108
Abstract: Estimating the effective reproduction number of Omicron subvariants is crucial for evaluating the effectiveness of control measures, and adjusting control measures promptly. We conducted a systematic review to synthesize the evidence from estimates of the… read more here.
Keywords: reproduction numbers; numbers sars; omicron subvariants; reproduction ... See more keywords
Emergence BQ.1 and BQ.1.1 as newly identified omicron subvariants: current scenario and future outlook – an update
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Medicine and Surgery"
DOI: 10.1097/ms9.0000000000000469
Abstract: Dear Editor, In the last couple of years, the Omicron variant has emerged as the deadliest among coronavirus disease 2019 (COVID-19) variants, and as a result, it has granted rise to several subvariants. According to… read more here.
Keywords: omicron; omicron subvariants; emergence newly; covid ... See more keywords
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Sign Up to like & getrecommendations! Published in 2022 at "Nature Communications"
DOI: 10.1101/2022.12.05.519085
Abstract: Recent Omicron SARS-CoV-2 subvariants independently acquire 5 key Spike mutations. Here, the authors evaluate the evolutionary importance of the 5 mutations and characterize the virological properties of variant BQ.1.1 harboring all 5 mutations. In late… read more here.
Keywords: omicron; omicron subvariants; omicron lineages; convergent evolution ... See more keywords
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Sign Up to like & getrecommendations! Published in 2022 at "Nature Communications"
DOI: 10.1101/2022.12.27.521986
Abstract: XBB is the first recombinant, globally dominant variant of SARS-CoV-2. Here, the authors examine the variant’s origins and virological properties, showing it is the first example of SARS-CoV-2 improving its fitness through recombination. In late… read more here.
Keywords: xbb; xbb variant; omicron subvariants; sars cov ... See more keywords
Immune evasion, infectivity, and membrane fusion of the SARS-CoV-2 JN.1 variant
Sign Up to like & getrecommendations! Published in 2025 at "Virology Journal"
DOI: 10.1186/s12985-025-02737-3
Abstract: SARS-CoV-2 undergoes continuous mutations during transmission, resulting in a variety of Omicron subvariants. Currently, SARS-CoV-2 BA.2.86 and its descendants JN.1, KP.2, KP.1.1 have been identified as the primary variants spreading globally. These emerging Omicron variants… read more here.
Keywords: sars cov; membrane fusion; infectivity; immune evasion ... See more keywords
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
Sign Up to like & getrecommendations! Published in 2022 at "PLOS ONE"
DOI: 10.1371/journal.pone.0279326
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants are expected to be resistant to Bebtelovimab (BEB) monoclonal antibody (MAb) and the real-world experience regarding its effectiveness is scarce. This retrospective cohort study reports a… read more here.
Keywords: monoclonal antibody; omicron subvariants; beb mab; cov omicron ... See more keywords